Sandy S Chang1, Carlos O Weiss, Qian-Li Xue, Linda P Fried. 1. Section of Geriatrics, Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520-8025, USA. sandy.chang@yale.edu
Abstract
BACKGROUND: Developing interventions to prevent frailty in older adults is a priority as it increases the risk for disability, institutionalization, and death. Single chronic inflammatory diseases are known to increase the risk of frailty. Identification of comorbid inflammatory diseases that synergistically might heighten this risk would provide further insight into therapeutic approaches to prevent frailty. The study aims were to characterize whether there are specific inflammatory disease pairs that are associated with frailty and to determine whether the risk of frailty is affected by synergistic interactions between these inflammatory diseases. METHODS: Data were from the Women's Health and Aging Studies I and II and complementary cohorts of community-dwelling women aged 70-79 years from Baltimore, Maryland (n = 620). Multivariable logistic regression analyses were performed to evaluate the relationships between these diseases and frailty. RESULTS: Among the frail (11.3%), 15.2% had both depressive symptoms and anemia and 14.5% had pulmonary disease and anemia. The risk of frailty was synergistically increased in those with depressive symptoms and anemia (adjusted risk ratios = 11.93, 95% confidence interval [CI] 4.10-34.76) and those with pulmonary disease and anemia (risk ratios = 5.57, 95% CI 2.14-14.48), compared with those without either disease in each pair. The attributable proportions of frail cases due to interaction between the diseases of each pair were 0.56 (95% CI 0.07-1.05) and 0.61 (95% CI 0.18-1.05), respectively. CONCLUSIONS: Synergistic interactions between specific inflammatory diseases may heighten the risk of frailty. These findings suggest that a common etiologic pathway may exist among co-occurring inflammatory diseases and that their improved comanagement may be an approach to reducing frailty.
BACKGROUND: Developing interventions to prevent frailty in older adults is a priority as it increases the risk for disability, institutionalization, and death. Single chronic inflammatory diseases are known to increase the risk of frailty. Identification of comorbid inflammatory diseases that synergistically might heighten this risk would provide further insight into therapeutic approaches to prevent frailty. The study aims were to characterize whether there are specific inflammatory disease pairs that are associated with frailty and to determine whether the risk of frailty is affected by synergistic interactions between these inflammatory diseases. METHODS: Data were from the Women's Health and Aging Studies I and II and complementary cohorts of community-dwelling women aged 70-79 years from Baltimore, Maryland (n = 620). Multivariable logistic regression analyses were performed to evaluate the relationships between these diseases and frailty. RESULTS: Among the frail (11.3%), 15.2% had both depressive symptoms and anemia and 14.5% had pulmonary disease and anemia. The risk of frailty was synergistically increased in those with depressive symptoms and anemia (adjusted risk ratios = 11.93, 95% confidence interval [CI] 4.10-34.76) and those with pulmonary disease and anemia (risk ratios = 5.57, 95% CI 2.14-14.48), compared with those without either disease in each pair. The attributable proportions of frail cases due to interaction between the diseases of each pair were 0.56 (95% CI 0.07-1.05) and 0.61 (95% CI 0.18-1.05), respectively. CONCLUSIONS: Synergistic interactions between specific inflammatory diseases may heighten the risk of frailty. These findings suggest that a common etiologic pathway may exist among co-occurring inflammatory diseases and that their improved comanagement may be an approach to reducing frailty.
Authors: Linda P Fried; Luigi Ferrucci; Jonathan Darer; Jeff D Williamson; Gerard Anderson Journal: J Gerontol A Biol Sci Med Sci Date: 2004-03 Impact factor: 6.053
Authors: Luigi Ferrucci; Jack M Guralnik; Richard C Woodman; Stefania Bandinelli; Fulvio Lauretani; Anna Maria Corsi; Paulo H M Chaves; William B Ershler; Dan L Longo Journal: Am J Med Date: 2005-11 Impact factor: 4.965
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Calvin Hirsch; Melissa L Anderson; Anne Newman; Willem Kop; Sharon Jackson; John Gottdiener; Russell Tracy; Linda P Fried Journal: Ann Epidemiol Date: 2006-01-04 Impact factor: 3.797
Authors: M A Bremmer; A T F Beekman; D J H Deeg; B W J H Penninx; M G Dik; C E Hack; W J G Hoogendijk Journal: J Affect Disord Date: 2007-08-22 Impact factor: 4.839
Authors: Mara A McAdams-DeMarco; Andrew Law; Jingwen Tan; Cassandra Delp; Elizabeth A King; Babak Orandi; Megan Salter; Nada Alachkar; Niraj Desai; Morgan Grams; Jeremy Walston; Dorry L Segev Journal: Transplantation Date: 2015-04 Impact factor: 4.939
Authors: Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen Journal: Endocr Rev Date: 2012-03-20 Impact factor: 19.871
Authors: René Rizzoli; Jean-Yves Reginster; Jean-François Arnal; Ivan Bautmans; Charlotte Beaudart; Heike Bischoff-Ferrari; Emmanuel Biver; Steven Boonen; Maria-Luisa Brandi; Arkadi Chines; Cyrus Cooper; Sol Epstein; Roger A Fielding; Bret Goodpaster; John A Kanis; Jean-Marc Kaufman; Andrea Laslop; Vincenzo Malafarina; Leocadio Rodriguez Mañas; Bruce H Mitlak; Richard O Oreffo; Jean Petermans; Kieran Reid; Yves Rolland; Avan Aihie Sayer; Yannis Tsouderos; Marjolein Visser; Olivier Bruyère Journal: Calcif Tissue Int Date: 2013-07-05 Impact factor: 4.333
Authors: P Abizanda; L Romero; P M Sánchez-Jurado; M Martínez-Reig; S A Alfonso-Silguero; L Rodríguez-Mañas Journal: J Nutr Health Aging Date: 2014 Impact factor: 4.075
Authors: Patrick Kierkegaard; Mira D Vale; Spencer Garrison; Brent K Hollenbeck; John M Hollingsworth; Jason Owen-Smith Journal: J Surg Oncol Date: 2019-12-23 Impact factor: 3.454
Authors: K Palmer; D L Vetrano; A Marengoni; A M Tummolo; E R Villani; N Acampora; R Bernabei; G Onder Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: Mara A McAdams-DeMarco; Jingwen Tan; Megan L Salter; Alden Gross; Lucy A Meoni; Bernard G Jaar; Wen-Hong Linda Kao; Rulan S Parekh; Dorry L Segev; Stephen M Sozio Journal: Clin J Am Soc Nephrol Date: 2015-11-16 Impact factor: 8.237